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Methocarbamol (ME), 2-hydroxy-3-(2-methoxyphenoxy) propyl carbamate (Fig. 1a),
is a centrally acting skeletal muscle relaxant whose action may be due to its general de-
pressant effects on the CNS. It is used as an adjunct in the short-term symptomatic treat-
ment of painful muscle spasms associated with musculoskeletal conditions and is some-
times given with analgesics for musculoskeletal pain treatment (1, 2). Ibuprofen (IB),
2-(4-isobutylphenyl) propionic acid (Fig. 1b), and diclofenac potassium (DI), potassium
[o-(2,6-dichloroanilino)phenyl] acetate (Fig. 1c), are non-steroidal drugs with anti-infla-
mmatory, antipyretic and analgesic properties (1). ME formulated with either IB or DI is
frequently prescribed to alleviate pain associated with muscle spasm. Guaifenesin (GU),
3-(2-methoxyphenoxy)-propane-1,2-diol (Fig. 1d), is considered as a substance related to
ME (1). Moreover, GU may be produced by ME hydrolysis, especially in alkaline me-
dium, and hence it is also considered to be the main degradation product of ME (2).
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There are many reports on the determination of ME, IB, DI and GU separately or in
combination with other drugs. Only a few methods have been reported for determina-
tion of either ME and IB or ME and DI in binary mixtures (3–12). Only one method has
been reported for determination of ME and DI in the presence of GU (13). This is an HPLC
method that uses gradient elution and different wavelengths.
Non of the reported spectrophotometric methods can be applied for simultaneous
determination of binary mixtures of ME and IB. No methods have been reported for de-
termination of ME and IB in the presence of GU.
Therefore, the objective of this work was to develop, simple, a sensitive and selec-
tive method for the determination of ME and its related substance GU in ternary mix-
tures with IB and DI. This is the first report on the determination of ME and IB in the
presence of GU.
EXPERIMENTAL
Standard samples and reagents
Standard ME and DI with certified purity of 99.80 and 99.97 %, respectively, were
kindly supplied by October Pharma S.A.E., Egypt. Standard IB with certified purity of
100.06 % was kindly supplied by El Kahira Co., Cairo, Egypt. Standard GU with certi-
fied purity of 99.95 % was kindly supplied by RAMEDA Co., Egypt.
All other reagents and chemicals used were of analytical grade and were used with-
out further purification. Methanol HPLC grade was from SDS, France.
Pharmaceutical formulations
Ibuflex® tablets were manufactured by Global Napi Pharmaceuticals. Each tablet is
claimed to contain 750 mg of ME and 400 mg of IB. Dimra® tablets were manufactured
by October Pharma S.A.E., Egypt. Each tablet is claimed to contain 500 mg of ME and 50
mg of DI.
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Fig 1. Chemical structure of: a) methocarbamol,
b) ibuprofen, c) diclofenac potassium.
Instruments and conditions
A double beam UV-Visible spectrophotometer (Shimadzu, Japan) model UV-1601 PC
with a quartz cell of 1 cm pathlength, connected to an IBM compatible computer, was
used. The software was UVPC personal spectroscopy software version 3.7. All computa-
tions were performed in Matlab for Windows™ version 6.5.
For HPLC analyses (3, 4), an HPLC (Shimadzu) instrument equipped with a model
series LC-10 ADVP pump, SCL-10 AVP controller, DGU-12 A degasser and SPD-10 AVP
UV-VIS detector was used. Separation and quantitation were made on a 250 ´ 4.6 mm
(i.d.) RP C18 column (4.6 mm particle size).
Standard solutions
Stock solutions for each of ME, IB and DI (1 mg mL–1) were prepared by dissolving
pure powder in methanol. The latter were diluted to 10 mg mL–1 with 0.1 mol L–1 HCl.
Each stock solution of ME, IB and DI was separately diluted ten times with metha-
nol to get a 100 mg mL–1 working solution of each of them.
Analytical procedures
The absorption spectra of 10 mg mL–1 of each of ME, DI, IB and GU in 0.1 mol L–1
HCl were recorded over the range 200–400 nm using 0.1 mol L–1 HCl as blank.
Linearity and calibration curves. – Aliquots equivalent to 40–200 mg ME and 40–220 mg
IB were transferred from their working standard solutions (100 mg mL–1) into two series
of 10-mL volumetric flasks, the volume was made up to the mark with 0.1 mol L–1 HCl
to obtain final concentration solutions of 4–20 mg mL–1 for ME and 4–22 mg mL–1 for IB.
Absorption spectra of the resulting solutions were measured in the range of 210–240 nm.
Scanned spectra of ME were divided by the absorption spectrum of 4 mg mL–1 of IB; the
same was applied to the spectra of IB divided by 4 mg mL–1 ME spectrum and the ob-
tained ratio spectra were mean centered for ME and IB mixture. The mean centered val-
ues at 218.4 nm for both ME and IB were recorded and plotted vs. the corresponding
concentrations. Regression equations were then computed.
Aliquots from working standard solutions (100 mg mL–1) equivalent to 40–200 mg
ME and 30–120 mg DI were also transferred into two series of 10-mL volumetric flasks
and the volume was made up with 0.1 mol L–1 HCl to get final solutions of 4–20 mg mL–1
for ME and 3–12 mg mL–1 for DI. Absorption spectra of the resulting solutions were mea-
sured in the range of 220–285 nm. Scanned spectra of ME were divided by the absorp-
tion spectrum of 6 mg mL–1 of DI while the spectra of DI were divided by the absorption
spectrum of 18 mg mL–1 of ME and the obtained ratio spectra were mean centered. The
mean centered values at 279.4 and 260.6 nm for ME and at 260.8 nm for DI were plotted
vs. the corresponding concentrations, and regression equations were computed.
Analysis of laboratory prepared mixtures. – Different mixtures containing ME and IB or
DI in different ratios were prepared. The procedure for each mixture was followed as
mentioned above. Concentrations of ME, IB, DI and GU were calculated by the corre-
sponding regression equation.
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Application to pharmaceutical preparations. – Ten tablets of Ibuflex® were accurately
weighed, then thoroughly powdered and mixed. An accurate weight of mixed powder
equivalent to 750 mg of ME and 400 mg of IB was transferred into a 250-mL beaker, 50
mL methanol were added and stirred magnetically for 10 minutes. The solution was fil-
tered into a 100-mL volumetric flask, and the volume was made up with methanol to ob-
tain a stock solution of concentration equivalent to 7.5 and 4 mg mL–1 of ME and IB, re-
spectively. Appropriate tenfold dilution of this stock solution was made to prepare a
solution equivalent to 75 and 40 mg mL–1 of ME and IB, respectively. The procedure de-
tailed under linearity and construction of the calibration curve for each mixture was fol-
lowed as mentioned above. Concentrations of ME and IB were calculated by the corre-
sponding regression equation.
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Fig. 2. Zero-order absorption spectra in 0.1 mol L–1 HCl for: a) 10 mg mL–1 methocarbamol (.........),
10 mg mL–1 guaifenesin (——) and 10 mg mL–1 ibuprofen (- – - – -), b) 10 mg mL–1 methocarbamol
(.........), 10 mg mL–1 guaifenesin (________) and 10 mg mL–1 diclofenac potassium (- – - – -).
As for Ibuflex® tablets, an appropriate dilution of stock solution was made to pre-
pare a solution equivalent to 75 and 40 mg mL–1 of ME and DI, respectively.
RESULTS AND DISCUSSION
The focus of this work was to develop simple, sensitive and accurate analytical me-
thods for simultaneous determination of ME and IB or DI in their binary mixtures. Mean
centering of the ratio spectra method (MCR, 14) was applied for simultaneous determi-
nation of the studied binary mixtures without prior separation steps. MCR method has
the advantage of eliminating the derivative steps and therefore the signal-to-noise ratio
is not degraded.
Method development and optimization
The zero-order absorption spectra of ME and IB or ME and DI mixtures show severe
overlapping (Figs. 2a,b), which did not allow us to use direct spectrophotometric mea-
surements for simultaneous determination of ME and IB or DI.
The effect of divisor concentration on the analytical parameters such as slope, inter-
cept and correlation coefficient was also tested. For the first mixture, 4 mg mL–1 of IB and
ME was used as a divisor for determination of both ME and IB at 218.4 nm. For the the
second mixture 6 mg mL–1 of DI was used as a divisor for determination of ME at 260.6
nm and 279.4 nm while 18 mg mL–1 of ME was used as a divisor for determination of DI
at 260.8 nm. The chosen divisior concentrations gave good results for the slope, intercept
and correlation coefficient of calibration graphs as well as for selectivity.
Method validation
Method validation was performed according to ICH the guidelines (15) for propo-
sed methods.
Linearity of the proposed methods was evaluated and it was evident in the range of
4–20 mg mL–1, 4–22 mg mL–1 for ME and IB, respectively, in the first mixture and 4–20 mg
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Table I. Regression parameters of the proposed MCR methods for determination of ME with IB or DI
Parameter Methocarbamol Ibuprofen Methocarbamol
Diclofenac
potassium
l (nm) 218.4 218.4 260.6 279.4 260.8
Calibration range
(mg mL–1)
4–20 4–22 4–20 4–20 3–12
Model accuracy 100.0 ± 0.9 100.0 ± 1.6 100.0 ± 1.6 100.2 ± 1.7 100.0 ± 1.0
LOD/LOQ (mg mL–1) 1.5/3.5 1.5/3.5 1.5/3 1.5/3 1.0/2
Intra-day RSD (%) 0.9 0.9 0.9 0.9 0.9
Inter-day RSD (%) 1.2 1.8 1.1 1.1 1.0
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mL–1, 3–12 mg mL–1 for ME and DI, respectively in the second mixture (Figs. 3a-d). The
regression equations for the proposed methods were calculated and found to be:
Y1 = 0.0825 g1 – 0.0612 R1 = 0.9999 for ME at 218.4 nm,
Y2 = 0.0726 g2 + 0.0165 R2 = 0.9996 for IB at 218.4 nm,
Y3 = 0.0463 g3 – 0.0104 R3 = 0.9997 for ME at 260.6 nm,
Y4 = 0.0785 g4 – 0.0173 R4 = 0.9997 for ME at 279.4 nm,
Y5 = 0.3412 g5 + 0.0548 R5 = 0.9997 for DI at 260.8 nm
where, Y1 and Y2 are peak amplitudes at the selected wavelengths for ME and IB, re-
spectively, while Y3, Y4 and Y5 are peak amplitudes at the selected wavelengths for ME
(two wavelengths) and DI, respectively; g1 and g2 are the concentrations in mg mL–1 for
ME and IB, respectively, while g3, g4 and g5 are the concentrations in mg mL–1 for ME (at
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Fig. 3. The mean centered first ratio absorption spectra in 0.1 mol L–1 HCl for: a) ibuprofen in the
range 4–22 mg mL–1 using the spectrum of 4 mg mL–1 ME as a divisor, b) methocarbamol in the
range 4–20 mg mL–1 using the spectrum of 4 mg mL–1 IB as a divisor, c) diclofenac potassium in the
range 3–12 mg mL–1 using the spectrum of 18 mg mL–1 of ME as a divisor, d) methocarbamol in the
range 4–20mg mL–1 using the spectrum of 6 mg mL–1 of DI as a divisor.
the corresponding wavelengths) and DI, respectively, whereas R1, R2, R3, R4 and R5 are
the respective correlation coefficients at the selected wavelengths. Good linearity is evi-
dent from the high value of the correlation coefficients (Table I).
Precision of the proposed methods is shown in Table I. Model accuracy of the pro-
posed methods was checked by applying the proposed methods to determination of pu-
re samples of the studied compounds and was found to be 100.0 % for ME and IB and
100.0 and 100.2 % for ME and DI, respectively. Concentrations were calculated from the
corresponding regression equations and the results are shown in Table I. Accuracy was
further assessed by applying the standard additions technique on Ibuflex® and Dimra®
tablets where good recoveries were obtained, revealing no interference from excipients
and good accuracy of the proposed methods (99.1 and 100.3 % for IB and ME, respec-
tively, and 101 and 100.1 % for DI and ME, respectively, Table II).
Specificity of the proposed methods is evident from the spectra shown in Figs. 3a-d.
Robustness of the proposed methods was evaluated in the development phase where
the effect of different factors on mean centering of the ratio spectra methods was studied
to obtain optimum parameters for complete separation (data not shown).
Table III shows statistical comparison of the results obtained by the proposed methods
and the reported HPLC methods (3, 4). The calculated t- and F-values are lower than the
theoretical ones, indicating that there is no significant difference between the proposed
methods and the reported method with respect to accuracy and precision.
CONCLUSIONS
The proposed methods are simple, selective and precise and could be easily applied
for simultaneous determination of ME and IB or ME and DI in their binary mixtures.
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S A @ E T A K
Simultano odre|ivanje metokarbamola i ibuprofena ili diklofenak
kalija metodom centriranja srednjih vrijednosti spektralnih omjera
(mean centering of the ratio spectra method)
NOURUDDIN WAGEIH ALI, MAHA AHAMD HEGAZY,
MOHAMED ABDELKAWY i EGLAL ABDELAHAMID ABDELALEEM
U radu su opisane to~ne i osjetljive metode za simultano odre|ivanje metokarba-
mola i ibuprofena ili diklofenak kalija u njihovim binarnim smjesama, te u prisutnosti
gvajfenezina, supstancije srodne metokarbamolu koriste}i metodu centriranja srednjih vri-
jednosti spektralnih omjera. Dobiveni rezultati su statisti~ki uspore|eni s objavljenim HPLC
metodama. Nije prona|ena zna~ajna razlika u to~nosti i preciznosti izme|u predlo`ene
metode i objavljenih metoda.
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